Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1862162rdf:typepubmed:Citationlld:pubmed
pubmed-article:1862162lifeskim:mentionsumls-concept:C0033371lld:lifeskim
pubmed-article:1862162lifeskim:mentionsumls-concept:C0040160lld:lifeskim
pubmed-article:1862162lifeskim:mentionsumls-concept:C0036341lld:lifeskim
pubmed-article:1862162lifeskim:mentionsumls-concept:C0011570lld:lifeskim
pubmed-article:1862162lifeskim:mentionsumls-concept:C0013806lld:lifeskim
pubmed-article:1862162lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:1862162lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:1862162lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:1862162lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:1862162pubmed:issue1lld:pubmed
pubmed-article:1862162pubmed:dateCreated1991-8-30lld:pubmed
pubmed-article:1862162pubmed:abstractTextThyroid stimulating hormone (TSH) and prolactin (PRL) plasma levels were studied during electroconvulsive therapy (ECT) in five schizophrenic patients in a simulated ECT (SECT) controlled experimental design. The data were compared to those obtained from a group of 10 depressed patients treated with ECT. In the schizophrenic group, both PRL and TSH increased significantly during ECT compared to SECT, as they did in the depressive group during ECT. Thus, the hormonal TSH and PRL profile during ECT is similar in schizophrenia and depression. It is concluded that the changes in TSH and PRL induced by ECT are specifically linked to the current or the seizure, and are not related to the type of psychopathology.lld:pubmed
pubmed-article:1862162pubmed:languageenglld:pubmed
pubmed-article:1862162pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1862162pubmed:citationSubsetIMlld:pubmed
pubmed-article:1862162pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1862162pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1862162pubmed:statusMEDLINElld:pubmed
pubmed-article:1862162pubmed:monthAprlld:pubmed
pubmed-article:1862162pubmed:issn0165-1781lld:pubmed
pubmed-article:1862162pubmed:authorpubmed-author:StefaniuAAlld:pubmed
pubmed-article:1862162pubmed:authorpubmed-author:Papadimitriou...lld:pubmed
pubmed-article:1862162pubmed:authorpubmed-author:PapakostasYYlld:pubmed
pubmed-article:1862162pubmed:authorpubmed-author:MarkianosMMlld:pubmed
pubmed-article:1862162pubmed:authorpubmed-author:LykourasLLlld:pubmed
pubmed-article:1862162pubmed:issnTypePrintlld:pubmed
pubmed-article:1862162pubmed:volume37lld:pubmed
pubmed-article:1862162pubmed:ownerNLMlld:pubmed
pubmed-article:1862162pubmed:authorsCompleteYlld:pubmed
pubmed-article:1862162pubmed:pagination5-10lld:pubmed
pubmed-article:1862162pubmed:dateRevised2008-4-17lld:pubmed
pubmed-article:1862162pubmed:meshHeadingpubmed-meshheading:1862162-...lld:pubmed
pubmed-article:1862162pubmed:meshHeadingpubmed-meshheading:1862162-...lld:pubmed
pubmed-article:1862162pubmed:meshHeadingpubmed-meshheading:1862162-...lld:pubmed
pubmed-article:1862162pubmed:meshHeadingpubmed-meshheading:1862162-...lld:pubmed
pubmed-article:1862162pubmed:meshHeadingpubmed-meshheading:1862162-...lld:pubmed
pubmed-article:1862162pubmed:meshHeadingpubmed-meshheading:1862162-...lld:pubmed
pubmed-article:1862162pubmed:meshHeadingpubmed-meshheading:1862162-...lld:pubmed
pubmed-article:1862162pubmed:meshHeadingpubmed-meshheading:1862162-...lld:pubmed
pubmed-article:1862162pubmed:meshHeadingpubmed-meshheading:1862162-...lld:pubmed
pubmed-article:1862162pubmed:meshHeadingpubmed-meshheading:1862162-...lld:pubmed
pubmed-article:1862162pubmed:year1991lld:pubmed
pubmed-article:1862162pubmed:articleTitleThyrotropin and prolactin responses to ECT in schizophrenia and depression.lld:pubmed
pubmed-article:1862162pubmed:affiliationAthens University Medical School Psychiatric Clinic, Greece.lld:pubmed
pubmed-article:1862162pubmed:publicationTypeJournal Articlelld:pubmed